Medical Xpress January 20, 2026
Céline Gravot-Schüppel, Helmholtz Association of German Research Centres

A new artificial intelligence (AI) method called BioPathNet helps researchers systematically search large biological data networks for hidden connections—from gene functions and disease mechanisms to potential therapeutic approaches. BioPathNet was developed by teams at Helmholtz Munich and Mila—Quebec Artificial Intelligence Institute in Montreal, Canada. The researchers have now published the method in the journal Nature Biomedical Engineering.

Interpretable AI connects genes, diseases, and drugs

Biomedical “knowledge graphs” are structured maps that link genes, proteins, diseases, drugs, and biological processes, capturing their relationships to help both humans and AI understand biology and medicine in a systematic way. However, these networks remain incomplete: Many relationships that researchers expect to exist have not yet been documented.

BioPathNet is an AI method for analyzing...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
The Download: OpenAI’s plans for science, and chatbot age verification
Around the nation: Amazon's One Medical launches new AI chatbot
The Medical Futurist’s 100 Digital Health And AI Companies Of 2026
Physician assistants say paperwork and AI training still lag
More Data Isn’t Always Better for AI Decisions

Share Article